A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study - Concepedia

Concepedia

Publication | Open Access

A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study

DOI Full Paper Access

198

Citations

32

References

2008

Year

Dominick J. Angiolillo, Piera Capranzano, Shinya Goto, Muhammad Hasnain Aslam, Ronald K. Charlton, Y. Suzuki, Lyndon C. Box, Steven B. Shoemaker, Martin M. Zenni, Luis A. Guzmán,

European Heart Journal

Abstract

Adjunctive treatment with cilostazol in T2DM patients on standard dual antiplatelet therapy enhances inhibition of platelet P2Y(12) signalling.

References

	Year	Citations

Page 1